AKT1 and hepatocellular carcinoma: Furthermore, we develop an engineered circular RNA that encodes a peptide containing p110α ABD domain, which effectively suppresses HCC tumor growth by simultaneously disrupting p85β/POLR1A condensates and inhibiting PI3K/AKT signaling pathway, offering a novel RNA-based therapeutic strategy against HCC.